drugset / Trial / NCT02577783
PDD vs PAD to Treat Initially Diagnosed MM
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether doxorubicin hydrochloride liposome is superior to doxorubicin when combined with bortizomib and dexamethasone for treating patient with initially diagnosed multiple myeloma.
Timeline
- Start
- 2015-10
- Primary completion
- 2021-10
- Completion
- 2021-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Doxorubicin | Other / unclassified | — | — |
| Background | Bortezomib | Small molecule | — | — |
| Background | Dexamethasone | Small molecule | — | — |